Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to TALK:PC53 20 |u:www.enterprize.cam.ac.uk.  Search for TALK:PC53 20 |u:www.enterprise.cam.ac.uk instead.
11 - 20 of 36 search results for TALK:PC53 20 |u:www.enterprise.cam.ac.uk or TALK:PC53 20 |u:www.enterprize.cam.ac.uk where 0 match all words and 36 match some words.
  1. Results that match 1 of 2 words

  2. Innovation.Partnership.Impact. ANNUAL REVIEW 2023 The University of…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/CE_Annual_Report23_WEB.pdf
    26 Mar 2024: 18 NuQuantum: pioneering Quantum Networking for transformative computing. 20 Establishing a home-grown, inclusive innovation roadmap to prosperity for Greater Cambridge. ... 06 OCTOBER. 20 MARCH. £29.8bn economic impact of the University of Cambridge
  3. Potential uses: • High throughput drug screening for therapeutic ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2011/09/Sin-2591-11V6_29052019.pdf
    29 May 2019: display contractile ability in response to carbachol treatment. There was a 10-20% change of surface area in contracting cells.
  4. patent process

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/patent-application-process.pdf
    7 Jul 2015: 0 months. Monopoly for 20 years from filing. 6 months 12 months 18 months 24 months 30 months 5 years.
  5. PowerPoint Presentation

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/04/Cambridge-Enterprise-Virus-Research-Reagents.pdf
    28 Apr 2020: 2009, 90,1202. J Virol. 2010, 84(20), 10937. 2. Herpes Simplex Virus Type 1 and 2 (HSV-1 and -2) antibodies.
  6. Cambridge innovation in numbersThe University sits at the heart ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/06/innovation_in_numbers_december_2021_2.pdf
    22 Dec 2021: 92%Of Cambridge Enterprise portfolio companies have a 5-year survival rate. £107.3m In translational research funding won with the support of Cambridge Enterprise 2011-20.
  7. Annual Review2020 /Where ideas thrive 2 Cambridge Enterprise Annual…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/01/Cambridge-Enterprise-Annual-Review-2020.pdf
    12 Mar 2021: £2bn. 4 Cambridge Enterprise Annual Review 2020. Some 20,000 people in Botswana are hearing impaired. ... 2019–20 £’000. 2018–19£’000. Investment in IP assets (patent and proof of concept) (1,075) (803).
  8. Annual Review 2015 Cambridge Enterprise LimitedUniversity of…

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/Annual_Report_v21_040116_screen.pdf
    4 Jan 2016: 20), taking viewers beyond the licences, patents and investments we oversee to illuminate the real-world impact of the research we support. ... Total expenditure (30,146) (18,880). Net income/(expenditure) for the year (156) (20).
  9. Annual Review 2016 111 In 2006 Cambridge Enterprise Limited ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2016_Annual_Report_corrected.pdf
    6 Mar 2017: Dr Mahadeva, Consultant Respiratory Physician at Addenbrooke’s Hospital (Director of Cambridge Antitrypsin Centre), Associate Lecturer, University of Cambridge, has a 20 year interest in AAT. ... The business of company creation. Spin-outs and start-ups
  10. UK University Technology Transfer: behind the headlinesA note from ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/05/behind-the-headlines.pdf
    8 May 2015: A recent UK review suggested that these stakes range from 20-67% in the UK and 5-100% in the US.
  11. UK University Technology Transfer: behind the headlinesA note from ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/Behind-the-headlines.pdf
    8 May 2015: A recent UK review suggested that these stakes range from 20-67% in the UK and 5-100% in the US.

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.